NASDAQ: AQST
Aquestive Therapeutics Inc Stock Ownership - Who owns Aquestive Therapeutics?

Insider buying vs selling

Have Aquestive Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Daniel BarberCEO;Pres2026-10-1525,000$4.22
$105.60kSell
Daniel BarberCEO;Pres2026-09-1525,000$4.82
$120.48kSell
Sherry KorczynskiCCO2026-09-098,750$5.22
$45.68kSell
Peter E. BoydCHRO2026-09-092,293$0.96
$2.20kBuy
Sherry KorczynskiCCO2026-09-098,750$2.65
$23.19kBuy
Daniel BarberCEO;Pres2026-09-0891,743$0.96
$88.07kBuy
Cassie JungCOO2026-09-034,587$0.96
$4.40kBuy
Daniel BarberCEO;Pres2026-08-1725,000$4.29
$107.18kSell
Sherry KorczynskiCCO2026-08-142,714$4.25
$11.53kSell
Daniel BarberCEO;Pres2026-07-1620,369$4.00
$81.52kSell

1 of 3

AQST insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AQST insiders and whales buy or sell their stock.

AQST Shareholders

What type of owners hold Aquestive Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Douglas K. Bratton1.56%1,963,890$7.86MInsider
Alexander Mark Schobel0.78%984,476$3.94MInsider
Keith J. Kendall0.51%639,149$2.56MInsider
Daniel Barber0.50%627,317$2.51MInsider
Stephen Wargacki0.27%343,552$1.37MInsider
Peter E. Boyd0.23%284,024$1.14MInsider
A. Ernest Toth Jr.0.23%283,460$1.13MInsider
Carl N. Kraus0.23%282,475$1.13MInsider
Melina Cioffi0.22%273,200$1.09MInsider
Sherry Korczynski0.19%235,689$942.76kInsider

1 of 3

AQST vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AQST0.06%5.95%Net SellingNet Buying
EVO0.00%0.00%
EOLS0.07%27.78%Net SellingNet Selling
KMDA0.01%45.13%Net SellingNet Selling
IRWD0.10%35.96%Net Selling

Aquestive Therapeutics Stock Ownership FAQ

Who owns Aquestive Therapeutics?

Aquestive Therapeutics (NASDAQ: AQST) is owned by 0.06% institutional shareholders, 5.95% Aquestive Therapeutics insiders, and 93.99% retail investors. Douglas K. Bratton is the largest individual Aquestive Therapeutics shareholder, owning 1.96M shares representing 1.56% of the company. Douglas K. Bratton's Aquestive Therapeutics shares are currently valued at $7.86M.

If you're new to stock investing, here's how to buy Aquestive Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.